What is the Org number of PharmaDirekt BR AB?

PharmaDirekt BR AB is registered with Bolagsverket / SCB under Org 5594723164.

What is the revenue of PharmaDirekt BR AB?

PharmaDirekt BR AB reported revenue of SEK 3,2M in 2025.

How many employees does PharmaDirekt BR AB have?

PharmaDirekt BR AB employs 4 people as of the latest annual report.

Who is the chairman of PharmaDirekt BR AB?

Roba Hallak chairs the board of PharmaDirekt BR AB, in role since 2024.

Where is PharmaDirekt BR AB headquartered?

PharmaDirekt BR AB's registered address is Blåbärsvägen 1.

PharmaDirekt BR AB

ABActive

Org 5594723164Blåbärsvägen 1Retail sale of pharmaceutical products · NACE 4773Est. 20244 employees

Revenue 2025

SEK 3,2M

+32% vs 2024

EBITDA margin

4.8%

-66% vs 2024

Equity ratio

29.5%

Financial strength

Net profit 2025

SEK 123K

-66% vs 2024

EBITDA — year on yearSEK millions

Key figuresAnnual report 2025

Revenue	SEK 3,2M	+32%
EBITDA	SEK 156K	-66%
Net profit	SEK 123K	-66%
Total assets	SEK 1,5M	+52%
Equity	SEK 448K	+17%
Employees	4	—

Item	2024	2025
Revenue	2 459	3 244
Staff expenses	−1 517	−2 029
EBITDA	452	156
Depreciation & amort.	—	—
EBIT	452	156
Net financials	0	0
Profit before tax	452	156
Tax	−94	−33
Net profit	359	123

Item	2024	2025
Total assets	1 001	1 521
Equity	384	448
Long-term debt	—	—
Short-term debt	618	1 072
Total debt	618	1 072

Name	Role	Member since
Current (2)
RH Roba Hallak	Deputy Board Member	2024
BD Bashar Daas Elias	Board of Directors	2024
Former (2)
AJ Anders Jakob Lindquist	Deputy Board Member	2024 – 2024
TN Torbjörn Nordberg	Board of Directors	2024 – 2024

Person	Role here	Other companies
Roba Hallak	Deputy Board Member	0 companies
Anders Jakob Lindquist	Deputy Board Member	0 companies
Bashar Daas Elias	Board of Directors	0 companies
Torbjörn Nordberg	Board of Directors	0 companies

PharmaDirekt BR AB

ABActive

Org 5594723164Blåbärsvägen 1Retail sale of pharmaceutical products · NACE 4773Est. 20244 employees

Revenue 2025

SEK 3,2M

+32% vs 2024

EBITDA margin

4.8%

-66% vs 2024

Equity ratio

29.5%

Financial strength

Net profit 2025

SEK 123K

-66% vs 2024

EBITDA — year on yearSEK millions

Key figuresAnnual report 2025

Revenue	SEK 3,2M	+32%
EBITDA	SEK 156K	-66%
Net profit	SEK 123K	-66%
Total assets	SEK 1,5M	+52%
Equity	SEK 448K	+17%
Employees	4	—